Drug Shortage Report for FOQUEST
Report ID | 151791 |
Drug Identification Number | 02470357 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-07 |
Actual start date | 2022-01-05 |
Estimated end date | 2024-08-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v135 | 2023-08-25 | English | Compare |
v134 | 2023-08-16 | French | Compare |
v133 | 2023-08-16 | English | Compare |
v132 | 2023-08-09 | French | Compare |
v131 | 2023-08-09 | English | Compare |
v130 | 2023-07-27 | French | Compare |
v129 | 2023-07-27 | English | Compare |
v128 | 2023-07-21 | French | Compare |
v127 | 2023-07-21 | English | Compare |
v126 | 2023-07-17 | French | Compare |
v125 | 2023-07-17 | English | Compare |
v124 | 2023-06-29 | French | Compare |
v123 | 2023-06-29 | English | Compare |
v122 | 2023-06-28 | English | Compare |
v121 | 2023-06-27 | French | Compare |
v120 | 2023-06-27 | English | Compare |
v119 | 2023-06-15 | French | Compare |
v118 | 2023-06-15 | English | Compare |
v117 | 2023-06-09 | French | Compare |
v116 | 2023-06-09 | English | Compare |